ISCHEMIC STROKE / COMPLICATIONS
Malignant Cerebral Infarction
Created 25/03/2021, last revision 23/09/2023
Definition
- malignant cerebral infarction = extensive infarction with large space-occupying edema
- occurs in up to 10% of patients with supratentorial infarcts
- it is traditionally associated with a high mortality rate (up to 80%) [Hacke, 1996]
- occurs mainly in cases of ICA and MCA occlusions or with posterior circulation strokes (mainly cerebellar infarctions)
- it is characterized by a development of edema within 24 h, clinical deterioration usually in < 72h, sometimes later (e.g., in case of collateral circulation failure and development of infarction in the penumbra
- early surgical decompression reduces mortality and increases the number of younger patients with a favorable outcome according to randomized controlled trials (RCTs)
Predictors of malignant infarction
Content available only for logged-in subscribers (registration will be available soon) |
Clinical features
- the initial severe neurological deficit with hemiplegia, deviation of eyes and head, high NIHSS, nausea, vomitus
- posterior circulation infarction is associated with altered consciousness, oculomotor dysfunction, altered brainstem reflexes, ataxia, and dysmetria
- progressive impairment of consciousness and conus symptoms due to craniocaudal deterioration
- Cushing’s triad is present in advanced stages of intracranial hypertension
- cardiovascular lability
- cerebellar infarctions are associated with an increased risk of brainstem compression and hydrocephalus development
Diagnostic evaluation
Imaging methods
- look for expansive behavior of ischemia and a midline shift on CT
- repeat brain CT within the first 48h in high-risk patients [AHA/ASA 2014 I/C]
- use MRI for early detection of large DWI lesions
- prediction of fulminant course within 6 h: DWI lesion > 80-89 mL
- prediction of fulminant course beyond 14 h: DWI lesion > 145 mL
Blood tests
- tests should exclude extracerebral causes of clinical deterioration
- a basic metabolic panel including hepatic enzymes
- minerals, including phosphate
- coagulation and blood count
- toxicology and ASTRUP should be considered in the presence of impaired consciousness not fully explained by structural changes on CT
Other methods
- EEG excludes nonconvulsive status epilepticus (unless NCCT correlates with the severe clinical condition)
- TCD / TCCD can be used to monitor blood flow
- occlusion detection (→ TIBI classification)
- signs of intracranial hypertension
- ICP monitoring
Differencial diagnosis
Content available only for logged-in subscribers (registration will be available soon) |
Management
Medical therapy |
- routine intensive care for acute stroke patients → see here
- consider transport to a hospital capable of performing acute decompressive craniectomy
- antiedema therapy
- osmotic therapy Mannitol / NaCl 10% (AHA/ASA 2019 IIa/C-LD)
- there are no data on the benefit of hypothermia, barbiturates, and corticosteroids in stroke patients and they are therefore not recommended
- therapy should be initiated only in patients with developing edema; prophylactic administration of osmotherapy is not recommended
- the effect of conservative treatment in malignant ischemia is usually insufficient and not clearly demonstrated
Surgery |
- preferred in younger patients
- don’t wait for the effect of drug therapy with developing malignant ischemia (as it has only minimal impact)
Cerebellar infarction
- ventriculostomy in case of obstructive hydrocephalus due to expansive cerebellar infarction (with or without craniectomy) (AHA/ASA 2019 I/C-LD)
- suboccipital craniectomy and resection of the infarcted tissue for expansive cerebral ischemia may be a life-saving procedure (AHA/ASA 2019 I/B-NR)
- ischemia leads to brainstem and aqueducts compression, so craniectomy can also relieve obstructive hydrocephalus
- it can be combined with the ventricular drainage
- imaging criteria
- compression of the 4th ventricle
- hydrocephalus
- basal cisterns/brainstem compression
- medial cerebellar infarction
Supratentorial infarction (usually MCA territory stroke)
- decompression releases pressure from the edematous tissue on adjacent tissue ⇒ ↓ ICP and ↑ CPP
- potentially life-saving procedure (see below for additional indication criteria)
- age < 60 years – a meta-analysis of the DESTINY, HAMLET a DECIMAL trials demonstrated that decompressive craniectomy within 48 hours in patients aged <60 years results in reduced mortality and improved outcome (AHA/ASA 2019 IIa/A)
- age > 60 years – reduced mortality alone was demonstrated in smaller studies [Won Yu, 2012] and randomized DESTINY II trial
- n = 112 (surgery 49 vs. control 63), age> 61 years
- mRS 0-4 39% (surgery) vs. 17% (control), ARR 22, NNT = 5 !!
- significant reduction of mortality (50%); compared to trials with patients < 60 years of age, there is a significant increase of survivors with very severe deficits and only a minimum of patients with mRS 3 (none 0-2) – questionable cost-effectiveness
- craniectomy diameter of at least 12 cm
- 14-15 cm anteroposteriorly
- 0-12 cm from the base to the vertex
- concomitant resection of infarcted tissue is rather not recommended
Indication criteria (used in the randomized trials)
- age 18 – 60 years (younger patients have a better prognosis, in the age of > 60y, mainly a reduction in mortality can be expected)
- NIHSS> 15
- somnolence-sopor
- ischemia > ½ of the MCA territory according to CT (with or without concurrent infarction in ACA or PCA on the same side)
- infarct volume > 145 cm3 according to DWI
- < 45 h (surgery completed < 48 h) from symptom onset
Exclusion criteria
- non-reactive, dilated pupils
- pre-morbid mRS ≥ 2
- extensive hemorrhagic component (type PH2)
- survival assumption <3 years due to severe comorbidities
- coagulopathy
- contraindications to general anesthesia (GA)
Clinical trials
Primary and secondary outcome | craniectomy | control |
mRS 0-4 / 1 year | 75% | 25% |
mRS 0-3 / 1 year | 43% | 21% |
survival | 78% | 29% |
DESTINY II [Jüttler, 2014]
- total n= 112
- decompressive craniectomy, n = 49
- control group, n = 63
- > 61 years of age
- mRS 0-4 39% (craniectomy) vs 17% (control), ARR 22, NNT = 5
- significant reduction in mortality, but only a small number of patients with mRS ≤ 3 !!!!
mRS | Decompressive craniectomy (%) | Control (%) |
3 | 6 | 4 |
4 | 33 | 14 |
5 | 26 | 12 |
6 | 35 | 70 |